Net Income

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

With strong growth and key acquisitions, Haemonetics' CEO will lay out the company's vision for 2026 at a high-stakes investor conference.

Amidst a market downturn, CNH brings in leaders from Rivian and Nikola to spearhead its ambitious transformation in autonomy, AI, and global operations.

Viomi Technology's $20M share repurchase program underscores faith in its 'Global Water' strategy, even as its stock faces a volatile market.

Online broker PU Prime partners with Argentina's AFA for a new campaign, but can a human-centric message overcome industry skepticism and user complaints?

Michelin is acquiring Cooley Group and Tex Tech Industries, pushing deeper into advanced materials for aerospace and healthcare as part of its 2030 strategy.

Ecovyst completes a major divestiture to slash debt and focus on its core, while Technip Energies acquires key assets to boost its energy transition goals.

Chinese auto giant GAC nearly tripled its exports in two years. Its secret? A hyper-localized strategy that is challenging incumbents worldwide.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

Insurtech firm PolicyStreet launches its largest promo yet, offering deep discounts and flexible payments to challenge traditional insurers in Malaysia.

As India's electric scooter sales surge, one insurer is shifting focus from policies to service, aiming to build trust with a new generation of riders.

A new national standard removes the mandatory mechanical steering link, paving the way for radical vehicle designs and cementing China's lead in auto tech.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

Despite falling revenue and supply chain chaos, CanadaBis posts positive cash flow, signaling a disciplined new strategy for survival and sustainability.

With a new leadership structure, Capital Bancorp aims to maximize its specialty finance units while reinforcing its core commercial banking operations.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

Nu Skin’s 2024 report reveals millions in donations, over 850 million meals provided, and major strides in sustainable sourcing and packaging.

With platinum prices soaring, junior miner ValOre Metals is pivoting to development at its unique Brazilian project, signaling a potential closing of its valuation gap.

A recent broadcast raised $5.2M for St. Jude, showcasing the power of Hispanic media and community philanthropy in the fight against childhood cancer.